Variants in genes affecting GLP-1 signaling and appetite regulation can offer useful context for personalization, but should be interpreted alongside your clinical history, biomarkers, and provider assessment
[1] [2] The primary mechanism of action involves: Appetite regulation : Saxenda acts on areas of the brain that control appetite, helping patients feel fuller for longer and reducing hunger between meals [1] [2] Slowing gastric emptying : The medication delays how quickly food leaves the stomach, contributing to prolonged satiety Blood glucose regulation : Although primarily used for weight management, liraglutide also influences insulin secretion and glucagon suppression Saxenda is administered as a once-daily subcutaneous injection, with the dose gradually increased over several weeks to minimise gastrointestinal side effects
Include fiber-rich foods to stay full longer
The relevance of mycotoxin toxicity for patients with ME/CFS, MCAS, and Long COVID cannot be overstated
These insights should be interpreted with a qualified healthcare provider who can integrate genetic data with your complete eye health assessment
/assets/images/provider/photos/2775905.jpeg)
